Targeting Ibrutinib to Tumor-Infiltrating T Cells with a Sialic Acid Conjugate-Modified Phospholipid Complex for Improved Tumor Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting Ibrutinib to Tumor-Infiltrating T Cells with a Sialic Acid Conjugate-Modified Phospholipid Complex for Improved Tumor Immunotherapy

Published:2022-11-16 Issue:1 Volume:20 Page:438-450
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Li Cong¹²,Fan Chuizhong¹,Lu Shuang¹,Qiu Qiujun¹,Gao Xin¹,Yan Xinyang¹,Wang Shuo¹,Zhao Bing³,Liu Xinrong¹,Song Yanzhi¹^ORCID,Deng Yihui¹^ORCID

Affiliation:

1. College of Pharmacy, Shenyang Pharmaceutical University, Shenyang110016, China

2. School of Pharmaceutical Science, Liaoning University, Shenyang110036, China

3. Faculty of Foreign Language, Shenyang Pharmaceutical University, Shenyang110016, China

Funder

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.2c00709

Reference51 articles.

1. Bifunctional lipids in tumor vaccines: An outstanding delivery carrier and promising immune stimulator

2. Risk analysis of leachables in cell and gene therapy using a CAR-T model process

3. PLAN B for immunotherapy: Promoting and leveraging anti-tumor B cell immunity

4. Fundamental Mechanisms of Immune Checkpoint Blockade Therapy

5. Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil-targeted liposomal platform: a shift in novel approach for early detection and treatment of cancer metastasis;Asian Journal of Pharmaceutical Sciences;2024-08

2. Regulation of sialic acid metabolism in cancer;Carbohydrate Research;2024-05

3. Bruton’s Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials;Molecules;2023-03-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3